galactosyl-(1-3)galactose has been researched along with gusperimus in 1 studies
| Studies (galactosyl-(1-3)galactose) | Trials (galactosyl-(1-3)galactose) | Recent Studies (post-2010) (galactosyl-(1-3)galactose) | Studies (gusperimus) | Trials (gusperimus) | Recent Studies (post-2010) (gusperimus) |
|---|---|---|---|---|---|
| 493 | 3 | 100 | 615 | 40 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gannedahl, G; Groth, CG; Sundberg, B; Tufveson, G | 1 |
1 trial(s) available for galactosyl-(1-3)galactose and gusperimus
| Article | Year |
|---|---|
The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti-porcine Gal-alpha (1,3)-Gal antibody titres in humans.
Topics: Animals; Antibodies, Heterophile; Antibody Formation; Antigens, Heterophile; Carbohydrate Sequence; Cyclophosphamide; Disaccharides; Enzyme-Linked Immunosorbent Assay; Guanidines; Humans; Immunosuppressive Agents; Molecular Sequence Data; Plasmapheresis; Swine | 1996 |